Insider · CIK 0001309653

AZAB MOHAMMAD

Reports to the SEC for 5 companies · BASKING RIDGE, NJ

sec.gov

Transactions

Companies

Filings

CIK

0001309653

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-01-09	LSTALISATA THERAPEUTICS, INC.A Award	Director	AAward	+30.5K sh	—	—	104,925
2025-09-11	DURECT CORPU Disposition from Tender	Director	UDisposition from Tender	−6,000 sh	—	—	0
2025-09-11	DURECT CORPStock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−5,500 sh	—	—	0
2025-09-11	DURECT CORPStock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−2,750 sh	—	—	0
2025-09-11	DURECT CORPStock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−5,500 sh	—	—	0
2025-09-11	DURECT CORPStock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−5,500 sh	—	—	0
2025-09-11	DURECT CORPStock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−7,000 sh	—	—	0
2025-01-09	LSTALISATA THERAPEUTICS, INC.A Award	Director	AAward	+15.8K sh	—	—	74,469
2024-09-25	DURECT CORPStock Option (right to buy)A Award	Director	AAward	+5,500 sh	—	—	5,500
2024-01-09	LSTALISATA THERAPEUTICS, INC.A Award	Director	AAward	+19.5K sh	—	—	58,680
2023-12-19	XENEXenon Pharmaceuticals Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−3,497 sh	—	—	0
2023-12-19	XENEXenon Pharmaceuticals Inc.M Exercise/Conversion	Director	MExercise/Conversion	+823 sh	$9.85	+$8,106.55	70,728
2023-12-19	XENEXenon Pharmaceuticals Inc.M Exercise/Conversion	Director	MExercise/Conversion	+3,497 sh	$9.85	+$34.4K	74,225
2023-12-19	XENEXenon Pharmaceuticals Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−823 sh	—	—	0
2023-06-21	DURECT CORPStock Option (right to buy)A Award	Director	AAward	+5,500 sh	—	—	5,500
2023-06-02	XENEXenon Pharmaceuticals Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+18.5K sh	—	—	18,475
2023-01-09	LSTALISATA THERAPEUTICS, INC.A Award	Director	AAward	+20K sh	—	—	39,200
2022-12-12	XENEXenon Pharmaceuticals Inc.M Exercise/Conversion	Director	MExercise/Conversion	+3,086 sh	$2.68	+$8,270.48	69,905
2022-12-12	XENEXenon Pharmaceuticals Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−3,086 sh	—	—	0
2022-09-15	LSTALISATA THERAPEUTICS, INC.A Award	Director	AAward	+19.2K sh	$6.25	+$120K	19,200
2022-06-28	XENEXenon Pharmaceuticals Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+18K sh	—	—	18,000
2022-06-15	DURECT CORPStock Option (right to buy)A Award	Director	AAward	+55K sh	—	—	55,000
2022-05-24	DURECT CORPP Purchase	Director	PPurchase	+10K sh	$0.39	+$3,889	55,000
2022-05-24	DURECT CORPP Purchase	Director	PPurchase	+5,000 sh	$0.39	+$1,950	60,000
2022-05-24	DURECT CORPP Purchase	Director	PPurchase	+5,000 sh	$0.38	+$1,894.5	45,000
2022-05-24	DURECT CORPP Purchase	Director	PPurchase	+5,000 sh	$0.39	+$1,942	40,000
2022-05-24	DURECT CORPP Purchase	Director	PPurchase	+5,000 sh	$0.39	+$1,962.5	35,000
2022-05-17	DURECT CORPP Purchase	Director	PPurchase	+8,900 sh	$0.42	+$3,748.68	28,200
2022-05-17	DURECT CORPP Purchase	Director	PPurchase	+9,300 sh	$0.42	+$3,899.49	19,300
2022-05-17	DURECT CORPP Purchase	Director	PPurchase	+1,800 sh	$0.42	+$758.34	30,000
2022-05-16	DURECT CORPP Purchase	Director	PPurchase	+10K sh	$0.38	+$3,767	10,000
2021-12-15	XENEXenon Pharmaceuticals Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−3,086 sh	—	—	0
2021-12-15	XENEXenon Pharmaceuticals Inc.M Exercise/Conversion	Director	MExercise/Conversion	+3,086 sh	$3.67	+$11.3K	66,819
2021-06-15	DURECT CORPStock Option (right to buy)A Award	Director	AAward	+27.5K sh	—	—	27,500
2021-06-03	XENEXenon Pharmaceuticals Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,000
2021-01-04	DURECT CORPStock Option (right to buy)A Award	Director	AAward	+70K sh	—	—	70,000
2020-12-15	XENEXenon Pharmaceuticals Inc.M Exercise/Conversion	Director	MExercise/Conversion	+3,086 sh	$3.76	+$11.6K	63,733
2020-12-15	XENEXenon Pharmaceuticals Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−3,086 sh	—	—	0
2020-06-01	XENEXenon Pharmaceuticals Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,000
2019-12-16	XENEXenon Pharmaceuticals Inc.M Exercise/Conversion	Director	MExercise/Conversion	+3,086 sh	$3.56	+$11K	60,647
2019-12-16	XENEXenon Pharmaceuticals Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−3,086 sh	—	—	0
2019-09-16	XENEXenon Pharmaceuticals Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+15K sh	—	—	15,000
2019-09-13	XENEXenon Pharmaceuticals Inc.S Sale	Director	SSale	−23 sh	$9.31	−$214.181	57,561
2018-12-06	XENEXenon Pharmaceuticals Inc.M Exercise/Conversion	Director	MExercise/Conversion	+3,086 sh	$3.07	+$9,474.02	57,584
2018-12-06	XENEXenon Pharmaceuticals Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−3,086 sh	—	—	0
2018-06-21	XENEXenon Pharmaceuticals Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−10.3K sh	—	—	0
2018-06-21	XENEXenon Pharmaceuticals Inc.M Exercise/Conversion	Director	MExercise/Conversion	+10.3K sh	$3.70	+$38.1K	54,498
2018-06-04	XENEXenon Pharmaceuticals Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+15K sh	—	—	15,000
2017-11-15	XENEXenon Pharmaceuticals Inc.P Purchase	Director	PPurchase	+15K sh	$2.22	+$33.3K	44,210
2017-09-22	XENEXenon Pharmaceuticals Inc.P Purchase	Director	PPurchase	+8,000 sh	$2.95	+$23.6K	29,210

Recent filings

Accepted (ET)
Jan 134
AZAB MOHAMMAD0001309653-26-000004
SEC(opens sec.gov)
Sep 124
AZAB MOHAMMAD0000950170-25-114645
SEC(opens sec.gov)
Jan 134
AZAB MOHAMMAD0001309653-25-000002
SEC(opens sec.gov)
Sep 274
AZAB MOHAMMAD0000950170-24-110013
SEC(opens sec.gov)
Jan 114
AZAB MOHAMMAD0001309653-24-000002
SEC(opens sec.gov)
Dec 204
AZAB MOHAMMAD0000950170-23-071929
SEC(opens sec.gov)
Jun 234
AZAB MOHAMMAD0001209191-23-039459
SEC(opens sec.gov)
Jun 24
AZAB MOHAMMAD0000950170-23-026195
SEC(opens sec.gov)
Jan 114
AZAB MOHAMMAD0001309653-23-000002
SEC(opens sec.gov)
Dec 134
AZAB MOHAMMAD0001209191-22-060939
SEC(opens sec.gov)
Sep 164
AZAB MOHAMMAD0001309653-22-000005
SEC(opens sec.gov)

Companies

Address

C/O LISATA THERAPEUTICS, INC, 110 ALLEN ROAD, 2ND FLOOR

BASKING RIDGE, NJ, 07920